NCT04452721

Brief Summary

Pectus carinatum is a deformation of the thoracic wall causing an aesthetic prejudice. Since 2011, our team uses a dynamic compression system to treat this deformation. It is a harness that the patient wears all day long for an average duration of 1 year, and that remodels the chest by exerting a moderate pressure on it. The local cohort is one of the largest in the world. The few previous publications have shown the validity of this method, but the prognosis factors for success of this innovative treatment are not yet identified.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
520

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 30, 2020

Completed
7 days until next milestone

Study Start

First participant enrolled

July 7, 2020

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

January 29, 2025

Status Verified

January 1, 2025

Enrollment Period

4.7 years

First QC Date

June 26, 2020

Last Update Submit

January 28, 2025

Conditions

Keywords

Pectus CarinatumDynamic compression system

Outcome Measures

Primary Outcomes (1)

  • Decrease of the deformation of more than 50% (measured in mm) after 6 months of treatment

    Dynamic compression system

    After 6 months of treatment

Secondary Outcomes (1)

  • Failure of treatment assessed by the patient, ie if the patients considers the treatment to have failed, if he choose to underwent surgery afterwards, or if he considered the pectus carinatum to have relapsed

    After the end of treatment (6 months to 2 years)

Study Arms (2)

Retrospective cohort

340 to 400 patients

Other: dynamic compression system

Validation cohort

120 patients

Other: dynamic compression system

Interventions

It is a harness that the patient wears all day long for an average duration of 1 year, and that remodels the chest by exerting a moderate pressure on it

Retrospective cohortValidation cohort

Eligibility Criteria

Age6 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Refusal to participate to this treatment

You may qualify if:

  • Patient who received proper information about the study.
  • Patient with clinically diagnosed pectus carinatum.
  • Treated at Saint-Etienne University Hospital using a dynamic compression system.
  • Between October 2011 and January 2020 for the retrospective part, then between January 2020 and January 2022 for the validation cohort.
  • With more than 6 months of follow-up since the beginning of the treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Saint-Etienne

Saint-Etienne, 42055, France

RECRUITING

Related Publications (1)

  • Kieffer De Marco L, Filaire L, Vermersch S, Chapelle C, Garcin A, Tiffet O, Scalabre A. Prognostic Factors for Pectus Carinatum Treated by Dynamic Compression System: PECTUSDYN Trial. Eur J Cardiothorac Surg. 2026 Jan 6;68(1):ezaf444. doi: 10.1093/ejcts/ezaf444.

MeSH Terms

Conditions

Pectus Carinatum

Condition Hierarchy (Ancestors)

Bone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesCartilage DiseasesMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesConnective Tissue DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Aurélien SCALABRE

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2020

First Posted

June 30, 2020

Study Start

July 7, 2020

Primary Completion

April 1, 2025

Study Completion

April 1, 2025

Last Updated

January 29, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations